ChemoCentryx
Utility Patents
Last updated:
List of all ChemoCentryx patents 56 in total
| Status | Patent |
|---|---|
Grant | Utility: 2-oxindole compounds Filling date: 8 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Heteroaryl sulfonamides and CCR2/CCR9 Filling date: 8 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Salt forms of a complement component C5A receptor Filling date: 8 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Immunomodulator compounds Filling date: 8 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Treatment of focal segmental glomerulosclerosis with CCR2 antagonists Filling date: 8 Sep 2025 Issue date: 12 Jul 2022 |
Grant | Utility: 6-5 fused rings as C5a inhibitors Filling date: 8 Sep 2025 Issue date: 12 Jul 2022 |
Grant | Utility: Method of treating liver fibrosis Filling date: 8 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Method of Treating Focal Segmental Glomerulosclerosis Filling date: 8 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor Filling date: 8 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Method of treating C3 glomerulopathy Filling date: 8 Sep 2025 Issue date: 29 Mar 2022 |
Grant | Utility: Triaryl compounds for treatment of PD-L1 diseases Filling date: 8 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Soluble C5aR antagonists Filling date: 8 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2 Filling date: 8 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Dosing and effect of C5a antagonist with ANCA-associated vasculitis Filling date: 8 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: Methods of treating solid tumors with CCR2 antagonists Filling date: 8 Sep 2025 Issue date: 26 Oct 2021 |
Grant | Utility: Substituted anilines as CCR(4) antagonists Filling date: 8 Sep 2025 Issue date: 12 Oct 2021 |
Grant | Utility: Indane-amines as PD-L1 antagonists Filling date: 8 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: Methods of treating pancreatic cancer Filling date: 8 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Macrocyclic immunomodulators Filling date: 8 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: CXCR7 antagonists Filling date: 8 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor type 9 (CCR9) and anti-.alpha.4.beta.7 integrin blocking antibodies Filling date: 8 Sep 2025 Issue date: 29 Jun 2021 |
Grant | Utility: Inhibitors of CXCR2 Filling date: 8 Sep 2025 Issue date: 22 Jun 2021 |
Grant | Utility: Free base crystalline form of a complement component C5a receptor Filling date: 8 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C--C chemokine receptor type 9 (CCR9) and anti-.alpha.4.beta.7 integrin blocking antibodies Filling date: 8 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Modulators of chemokine receptors Filling date: 8 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Method of treating focal segmental glomerulosclerosis Filling date: 8 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Immunomodulator compounds Filling date: 8 Sep 2025 Issue date: 16 Feb 2021 |
Grant | Utility: Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 |
Grant | Utility: Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors Filling date: 8 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies Filling date: 8 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: CCR6 compounds Filling date: 8 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: 2-oxindole compounds Filling date: 8 Sep 2025 Issue date: 1 Sep 2020 |
Grant | Utility: Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors Filling date: 8 Sep 2025 Issue date: 1 Sep 2020 |
Grant | Utility: Treatment of focal segmental glomerulosclerosis with CCR2 antagonists Filling date: 8 Sep 2025 Issue date: 1 Sep 2020 |
Grant | Utility: Diazole lactams Filling date: 8 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: 5-5 fused rings as C5a inhibitors Filling date: 8 Sep 2025 Issue date: 16 Jun 2020 |
Grant | Utility: Method of treating liver fibrosis Filling date: 8 Sep 2025 Issue date: 16 Jun 2020 |
Grant | Utility: C5aR antagonists Filling date: 8 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists Filling date: 8 Sep 2025 Issue date: 12 May 2020 |
Grant | Utility: Immunomodulator compounds Filling date: 8 Sep 2025 Issue date: 5 May 2020 |
Grant | Utility: Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides Filling date: 8 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Methods of treating pancreatic cancer Filling date: 8 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Indane-amines as PD-L1 antagonists Filling date: 8 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors Filling date: 8 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: 6-5 fused rings as C5a inhibitors Filling date: 8 Sep 2025 Issue date: 18 Feb 2020 |
Grant | Utility: Processes and intermediates in the preparation of C5aR antagonists Filling date: 8 Sep 2025 Issue date: 14 Jan 2020 |
Grant | Utility: Heteroaryl sulfonamides and CCR2/CCR9 Filling date: 8 Sep 2025 Issue date: 14 Jan 2020 |
Grant | Utility: Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor 9 (CCR9) and anti-.alpha.4.beta.7 integrin blocking antibodies Filling date: 8 Sep 2025 Issue date: 14 Jan 2020 |
Grant | Utility: Soluble C5aR antagonists Filling date: 8 Sep 2025 Issue date: 26 Nov 2019 |
Grant | Utility: Substituted tetrahydropyrans as CCR2 modulators Filling date: 8 Sep 2025 Issue date: 5 Nov 2019 |
Showing 1 to 50 of 56 patents.